USG guided brachial plexus block: A comparison of analgesia duration using Bupivacaine with and without Dexamethasone as adjuvant.
Trial Snapshot
- Phase
- Phase 3
- Status
- Other
- Sponsor
- IAF
- Enrollment
- 32
- Locations
- 1
- Primary Endpoint
- Compare the duration of Analgesia of brachial plexus block and time to first additional analgesic
Study Overview
Brief Summary
Brachial plexus block is one of the preferred techniques for anaesthesia for upper limb surgeries. The advantage being that of analgesia lasting even after the anaesthesia with motor block wears off. Many adjuvants have been explored for co-administration along with the local anaesthetic to prolong this period. Each of these adjuvants has its own side effect profile, with this study we will attempt at understanding the analgesic effect and duration and also the side effect profile by comparing blood sugar levels and duration of motor blockade.
Study Design
- Study Type
- Interventional
- Allocation
- Other
- Masking
- Participant, Investigator and Outcome Assessor Blinded
Eligibility Criteria
- Ages
- 18.00 Year(s) to 70.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Posted for Open Reduction Internal Fixation of UpperLimb fractures
- •Upper limb surgery where Supraclavicular brachial plexus block is indicated.
Exclusion Criteria
- •Weight less than 40 Kg
- •Pregnancy
- •Poor sensorium (GCS < 13)
- •Contraindications to Dexamethasone
- •Diabetes Mellitus
- •Patients on current steroid therapy or within past 6 weeks.
Outcomes
Primary Outcomes
Compare the duration of Analgesia of brachial plexus block and time to first additional analgesic
Time Frame: Measured over 48 hours
Secondary Outcomes
- Duration of motor weakness of arm measured every 6 hours(Measured over 48 hours)
- Postoperative blood sugar every 6 hours(Measured over 48 hours)
